The findings were published in the Neurology journal by Chien-Chih Chou and colleagues in a study titled Glaucoma Risk ...
HealthDay News — For chronic migraine, most calcitonin gene-related peptide (CGRP)-targeted therapies are probably effective for prophylaxis, according to a review published online May 5 in the Annals ...
The use of calcitonin gene-related peptide (CGRP) inhibitors to treat adults with migraine is linked to a 25% lower risk for ...
MedPage Today on MSN
Can migraine drugs guard against glaucoma? CGRP inhibitors show promise
Lower glaucoma rates emerge in large migraine cohort study ...
People taking CGRP (calcitonin gene-related peptide) inhibitors had a 25% lower risk of developing glaucoma, compared to those taking other migraine meds, researchers report in the journal Neurology ...
For adults with migraine receiving preventive treatment, use of calcitonin gene-related peptide inhibitors (CGRPi) is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results